LON:C4XD

C4X Discovery (C4XD) Share Price, News & Analysis

GBX 12
+2.58 (+27.32%)
(As of 04/25/2024)
Today's Range
8.30
12
50-Day Range
7.35
14.85
52-Week Range
7
22
Volume
3.77 million shs
Average Volume
1.18 million shs
Market Capitalization
£30.27 million
P/E Ratio
300.00
Dividend Yield
N/A
Price Target
N/A
C4XD stock logo

About C4X Discovery Stock (LON:C4XD)

C4X Discovery Holdings plc operates as drug discovery company in the United Kingdom. The company provides Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing 4D molecules in virtual reality research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. Its product pipeline includes Orexin-1, a receptor antagonist for the treatment of addictive disorders; NRF-2 activator to treat various inflammatory diseases; IL-17A inhibitor for inflammation diseases; a4ß7 integrin inhibitors for the treatment of inflammatory bowel disease; and MALT-1 inhibitors to treat hematological cancer. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was incorporated in 2007 and is based in Manchester, the United Kingdom.

C4XD Stock Price History

C4XD Stock News Headlines

C4X Discovery Holdings PLC C4XD
AstraZeneca payout pushes C4X share price up 50%
C4X Discovery Holdings PLC Announces Half Year Results
C4X Discovery Holdings plc (C4XD.L)
C4XD.L - | Stock Price & Latest News | Reuters
See More Headlines
Receive C4XD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/29/2020
Today
5/17/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
£10.57 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£24.68 million
Cash Flow
GBX 3 per share
Book Value
GBX 10 per share

Miscellaneous

Free Float
N/A
Market Cap
£30.27 million
Optionable
Not Optionable
Beta
0.23
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Dr. Clive James Dix B.Sc. (Age 70)
    Ph.D., Interim Executive Chairman & CEO
    Comp: $211k
  • Mr. Bradley Richard Hoy (Age 62)
    CFO, Secretary & Executive Director
    Comp: $242k
  • Ms. Bhavna Hunjan (Age 39)
    Chief Business Officer & Executive Director
    Comp: $218k
  • Ms. Emma Blaney Ph.D.
    Chief Operating Officer
  • Dr. Nick Ray Ph.D.
    Chief Scientific Officer
  • Dr. Clare Murray Ph.D.
    Senior Vice President of Drug Discovery

C4XD Stock Analysis - Frequently Asked Questions

Should I buy or sell C4X Discovery stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for C4X Discovery in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" C4XD shares.
View C4XD analyst ratings
or view top-rated stocks.

How have C4XD shares performed in 2024?

C4X Discovery's stock was trading at GBX 9 at the start of the year. Since then, C4XD shares have increased by 33.3% and is now trading at GBX 12.
View the best growth stocks for 2024 here
.

How were C4X Discovery's earnings last quarter?

C4X Discovery Holdings plc (LON:C4XD) posted its quarterly earnings data on Wednesday, April, 29th. The company reported ($5.02) EPS for the quarter, beating the consensus estimate of ($5.50) by $0.48. C4X Discovery had a net margin of 42.81% and a trailing twelve-month return on equity of 55.38%.

What other stocks do shareholders of C4X Discovery own?

Based on aggregate information from My MarketBeat watchlists, some companies that other C4X Discovery investors own include Rio Tinto Group (RIO), Ryder System (R), Pearson (PSON), Moss Bros Group (MOSB), Inland Homes (INL), Fundsmith Emerging Equities Trust (FEET), easyJet (EZJ), Card Factory (CARD) and The Berkeley Group (BKG).

How do I buy shares of C4X Discovery?

Shares of C4XD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:C4XD) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners